Literature DB >> 2766018

Treatment of liver tumors with yttrium-90 microspheres alone.

R J Blanchard1, I M Morrow, J B Sutherland.   

Abstract

Fifteen patients with liver metastases and one patient with hepatoma were treated by infusing 15 microns diameter plastic microspheres containing yttrium-90 into the hepatic artery. Twenty additional patients were screened but were found to be unsuitable for treatment. Follow-up angiography was done in 13 of the 16 treated patients. In five patients there was a reduction in tumor volume by more than 50% and in another two patients there was a smaller reduction. In six patients gastritis or gastric ulceration occurred and in three this was demonstrated to be due to unintended infusion of microspheres into the gastric circulation. For patients treated with yttrium-90 microspheres, mean survival time after referral was 62 weeks and in the untreated group it was 30 weeks, although this difference was not significant. We conclude that yttrium-90 microspheres alone can effect reduction in the size of liver tumors in some patients in whom their use is feasible.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766018

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  11 in total

1.  Hepatic radioembolization complicated by gastrointestinal ulceration.

Authors:  Jeremy Collins; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.

Authors:  Maren Bienert; Barry McCook; Brian I Carr; David A Geller; Mike Sheetz; Cecilia Tutor; Nikhil Amesur; Norbert Avril
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-17       Impact factor: 9.236

3.  Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

Authors:  S Ho; W Y Lau; T W Leung; M Chan; Y K Ngar; P J Johnson; A K Li
Journal:  Eur J Nucl Med       Date:  1996-08

4.  Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?

Authors:  Vanessa L Gates; Ryan Hickey; Karen Marshall; Melissa Williams; Krystina Salzig; Robert J Lewandowski; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-21       Impact factor: 9.236

Review 5.  Status of colorectal cancer devices: present scenario.

Authors:  Shammy Chandel; Reyhan Akhtar; Pooja Sarotra; Bikash Medhi
Journal:  J Gastrointest Cancer       Date:  2015-06

6.  Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol.

Authors:  Shahram Akhlaghpoor; Alireza Aziz-Ahari; Mahasti Amoui; Shahnaz Tolooee; Hossein Poorbeigi; Shahab Sheybani
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

7.  Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.

Authors:  Ozlem N Kucuk; Cigdem Soydal; Seda Lacin; Elgin Ozkan; Sadik Bilgic
Journal:  World J Surg Oncol       Date:  2011-08-06       Impact factor: 2.754

8.  Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.

Authors:  W Y Lau; W T Leung; S Ho; N W Leung; M Chan; J Lin; C Metreweli; P Johnson; A K Li
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

9.  Yttrium-90 microsphere induced gastrointestinal tract ulceration.

Authors:  Christopher D South; Marty M Meyer; Gregory Meis; Edward Y Kim; Fred B Thomas; Ali A Rikabi; Hooman Khabiri; Mark Bloomston
Journal:  World J Surg Oncol       Date:  2008-09-02       Impact factor: 2.754

10.  Excessive Hepatic Arterial-portal Venous Shunting May Predict Failure of Microparticle Localization in Hepatocellular Carcinomas.

Authors:  Andrew Eik Hock Tan; Yung Hsiang Kao; Wanying Xie
Journal:  World J Nucl Med       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.